MediaMedic

The Role of SHP-1 and SHP-2 in CD8+ T Cell Regulation during Lymphocytic Choriomeningitis Virus Infection: Insights into Stage-Specific Functional Interplay

By Mourabit Halima 2024.03.18

Abstract: Our study delves into the intricate interplay between Src homology region 2 domain-containing phosphatases 1 and 2 (SHP-1 and SHP-2) in orchestrating the functionality of CD8+ T cells during…

Assessing the Impact of Omicron Variant on Allo-HSCT Recipients in China: Insights from a Single-Center Observational Study

By Mourabit Halima 2024.03.17

Introduction: The emergence of the Omicron variant of SARS-CoV-2 has posed significant challenges to global public health systems. Among vulnerable populations, allo-hematopoietic stem cell transplantation (allo-HSCT) recipients represent a particularly…

The Complex Impact of CMV Reactivation Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comprehensive Review

By Qingyuan Liu 2024.03.17

Abstract: Cytomegalovirus (CMV) reactivation presents a formidable challenge for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with implications for overall mortality (OM) and non-relapse mortality (NRM) that are subject…

Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Option for Diffuse Large B-Cell Lymphoma Patients After CAR-T Therapy Failure

By Yang Xiaoshan 2024.03.17

Abstract: Refractory/relapsed diffuse large B-cell lymphoma (R/R DLBCL) poses significant therapeutic challenges, particularly in cases where chimeric antigen receptor T-cell (CAR-T) therapy fails. This retrospective study aimed to evaluate the…

Exploring CD22 as an Alternative Target in B-cell Hematologic Malignancies: A Comprehensive Review of Study Design, Clinical Implications, and Future Perspectives

By Mourabit Halima 2024.03.17

Abstract: Chimeric antigen receptor (CAR)-T cell therapy targeting CD19 has revolutionized the treatment landscape for patients with relapsed or refractory (R/R) B-cell malignancies. However, the emergence of relapse with CD19-negative…

$Bispecific CS1-BCMA CAR-T Cells Show Promise in Treating Relapsed or Refractory Multiple Myeloma: Phase I Clinical Trial Results$

Bispecific CS1-BCMA CAR-T Cells Show Promise in Treating Relapsed or Refractory Multiple Myeloma: Phase I Clinical Trial Results

By Mourabit Halima 2024.03.17

Abstract: Multiple myeloma (MM) poses significant therapeutic challenges due to its heterogeneous nature. Bispecific chimeric antigen receptor T (CAR-T) cell therapy targeting CS1 and BCMA antigens offers a novel approach.…

Evaluating the Efficacy and Safety of Orelabrutinib-Based Regimens in Diffuse Large B-Cell Lymphoma: A Retrospective Analysis

By Mourabit Halima 2024.03.17

Abstract: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous malignancy associated with significant morbidity and mortality. Orelabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown promise as a therapeutic agent…

Retrospective Analysis of bZIP Region Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia: Implications for Prognosis and Treatment

By Mourabit Halima 2024.03.17

Editor's note: Acute Myeloid Leukemia (AML) characterized by CCAAT-enhancer binding protein alpha (CEBPA) double mutations (CEBPAdm) represents a distinct subtype with varying clinical outcomes. Recent attention has focused on the…

The Impact of CEBPA Mutations in Hematological Disorders: A Comprehensive Study

By Mourabit Halima 2024.03.17

Editor's note: Genetic mutations play a pivotal role in shaping the clinical presentation and prognosis of hematological disorders, with CEBPA mutations emerging as significant contributors to disease pathogenesis. This comprehensive…

Pediatric-Inspired Therapy Revolutionizes Treatment of Adult Acute Lymphoblastic Leukemia: Insights from a Groundbreaking Chinese Study

By Mourabit Halima 2024.03.15

Introduction: Acute lymphoblastic leukemia (ALL) poses significant challenges in adult patient care, necessitating innovative treatment strategies. Addressing this need, a pioneering study conducted in China investigated the efficacy and safety…

Professor Lei Wang: Applications of Holographic Imaging in Partial Nephrectomy

A New Chapter of Innovation: Fudan University Shanghai Cancer Center Officially Establishes Its Urologic Oncology Center

Professor Lei Wang: Applications of Holographic Imaging in Partial Nephrectomy

Professor Aili Zhang: Rapid Testosterone Suppression, Stable Inhibition, and Long-Term Management—Reassessing the Role of LHRH Antagonists in Prostate Cancer ADT

CSCO 2026 | Professor Yungan Tao: Perioperative Immunotherapy Combined with Local Treatment Is Reshaping the Head and Neck Cancer Treatment Landscape

Growing Alongside CSCO | Professor Rui Ge: Gaining Knowledge and Friendship at CSCO While Exploring the Path to Precision Oncology

CSCO: A Global Perspective | Leaders from ASCO, ESMO, and CSCO Convene to Discuss a New Landscape for Global Collaboration in Cancer Care

Professor Wing Cheong Chow: Controversies, Risk-Stratified Pathways, and Localization of Breast Cancer Screening Strategies in Asia | 2026 Lingnan Breast Cancer Academic Forum

CSCO 2026 | Professor Qiang Wei: Real-World Evidence Further Validates the Clinical Benefits of Enzalutamide-Based Combination Therapy in Older, Frail, and Comorbidity-Burdened Patients With mCSPC

A New Beginning Through Comprehensive Prostate Cancer Care | Professor Benkang Shi: ADT Continues to Evolve—Precision Castration and Combination Therapy Transforming Prostate Cancer Management Across the Disease Continuum

Professor Lei Wang: Applications of Holographic Imaging in Partial Nephrectomy

A New Chapter of Innovation: Fudan University Shanghai Cancer Center Officially Establishes Its Urologic Oncology Center

The Role of SHP-1 and SHP-2 in CD8+ T Cell Regulation during Lymphocytic Choriomeningitis Virus Infection: Insights into Stage-Specific Functional Interplay

Assessing the Impact of Omicron Variant on Allo-HSCT Recipients in China: Insights from a Single-Center Observational Study

The Complex Impact of CMV Reactivation Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comprehensive Review

Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Option for Diffuse Large B-Cell Lymphoma Patients After CAR-T Therapy Failure

Exploring CD22 as an Alternative Target in B-cell Hematologic Malignancies: A Comprehensive Review of Study Design, Clinical Implications, and Future Perspectives

Bispecific CS1-BCMA CAR-T Cells Show Promise in Treating Relapsed or Refractory Multiple Myeloma: Phase I Clinical Trial Results

Evaluating the Efficacy and Safety of Orelabrutinib-Based Regimens in Diffuse Large B-Cell Lymphoma: A Retrospective Analysis

Retrospective Analysis of bZIP Region Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia: Implications for Prognosis and Treatment

The Impact of CEBPA Mutations in Hematological Disorders: A Comprehensive Study

Pediatric-Inspired Therapy Revolutionizes Treatment of Adult Acute Lymphoblastic Leukemia: Insights from a Groundbreaking Chinese Study

Professor Lei Wang: Applications of Holographic Imaging in Partial Nephrectomy

A New Chapter of Innovation: Fudan University Shanghai Cancer Center Officially Establishes Its Urologic Oncology Center

Professor Lei Wang: Applications of Holographic Imaging in Partial Nephrectomy

Professor Aili Zhang: Rapid Testosterone Suppression, Stable Inhibition, and Long-Term Management—Reassessing the Role of LHRH Antagonists in Prostate Cancer ADT

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.